AC Immune (ACIU) Receivables (2015 - 2024)

AC Immune (ACIU) has 6 years of Receivables data on file, last reported at $1.3 million in Q4 2024.

• On a quarterly basis, Receivables fell 99.99% year-over-year to $1.3 million in Q4 2024; TTM through Dec 2024 was $1.3 million, a 99.99% decrease from a year earlier, with the FY2024 full-year figure at $1.3 million, down 99.99% from the prior year.
• Receivables for Q4 2024 stood at $1.3 million, down from $29.4 million in the prior quarter.
• Over the last five years, Receivables for ACIU reached as high as $16.7 billion in Q4 2023 and fell as low as $1.3 million in Q4 2024.
• Historically, Receivables has averaged $2.5 billion across 4 years, with a median of $31.6 million in 2020.
• Across the five-year window, Receivables soared 610.64% in 2021 and slumped 99.99% in 2024, its largest moves.
• Year by year, Receivables stood at $66.4 million in 2020, then surged by 610.64% to $471.6 million in 2021, then surged by 3437.7% to $16.7 billion in 2023, then slumped by 99.99% to $1.3 million in 2024.
• Per Business Quant data, the three most recent Receivables figures were $1.3 million in Q4 2024, $29.4 million in Q3 2024, and $1.3 million in Q2 2024.